{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:17:42Z","timestamp":1778746662921,"version":"3.51.4"},"reference-count":37,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2026.15622","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T05:59:00Z","timestamp":1777269540000},"page":"1-15","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the mechanism of action of glaucocalyxin D against acute myeloid leukemia using network pharmacology, molecular docking and cellular experiments"],"prefix":"10.3892","volume":"31","author":[{"given":"Lian","family":"Chen","sequence":"first","affiliation":[{"name":"College of Pharmaceutical Science, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixian","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Anshun City People's Hospital, Anshun, Guizhou 561000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Luo","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Natural Products Research Center of Guizhou Province, Guizhou Medical University, Guiyang, Guizhou 550014, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Yan","sequence":"additional","affiliation":[{"name":"College of Pharmaceutical Science, Guizhou University of Traditional Chinese Medicine, Guiyang, Guizhou 550025, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"key20260514105821_b1-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.gde.2020.02.019","article-title":"Cancer and myeloid clonal evolution in the short telomere syndromes","volume":"60","author":"Schratz","year":"2020","journal-title":"Curr Opin Genet Dev"},{"key":"key20260514105821_b2-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1053\/j.seminhematol.2018.08.001","article-title":"Genetic and epigenetic determinants of AML pathogenesis","volume":"56","author":"Cai","year":"2019","journal-title":"Semin Hematol"},{"key":"key20260514105821_b3-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1002\/ajh.24648","article-title":"Diagnostic work-up of acute myeloid leukemia","volume":"92","author":"Weinberg","year":"2017","journal-title":"Am J Hematol"},{"key":"key20260514105821_b4-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"100703","DOI":"10.1016\/j.drup.2020.100703","article-title":"Genetic biomarkers of drug resistance: A compass of prognosis and targeted therapy in acute myeloid leukemia","volume":"52","author":"Long","year":"2020","journal-title":"Drug Resist Updat"},{"key":"key20260514105821_b5-ol-31-6-15622","first-page":"881","article-title":"Advanced natural products chemistry research in China between 2015 and 2017","volume":"16","author":"Yang","year":"2018","journal-title":"Chin J Nat Med"},{"key":"key20260514105821_b6-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.pdpdt.2019.04.033","article-title":"Photodynamic therapy for cancer: Role of natural products","volume":"26","author":"Mansoori","year":"2019","journal-title":"Photodiagnosis Photodyn Ther"},{"key":"key20260514105821_b7-ol-31-6-15622","first-page":"54","article-title":"New research progress on Rabdosia japonica var. glaucocalyx","volume":"32","author":"Gao","year":"2011","journal-title":"J Mudanjiang Med Univ"},{"key":"key20260514105821_b8-ol-31-6-15622","first-page":"155","article-title":"Research progress on Chinese herbal medicine isodon","volume":"7","author":"Su","year":"2011","journal-title":"Asia Pac Tradit Med"},{"key":"key20260514105821_b9-ol-31-6-15622","first-page":"651","article-title":"Research progress on the biological activities of diterpenoids from isodon (lamiaceae)","volume":"21","author":"Dong","year":"2010","journal-title":"China Pharm"},{"key":"key20260514105821_b10-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"418","DOI":"10.7150\/ijbs.23602","article-title":"Glaucocalyxin A induces G2\/M cell cycle arrest and apoptosis through the PI3K\/Akt pathway in human bladder cancer cells","volume":"14","author":"Lin","year":"2018","journal-title":"Int J Biol Sci"},{"key":"key20260514105821_b11-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"106271","DOI":"10.1016\/j.intimp.2020.106271","article-title":"Glaucocalyxin A alleviates LPS-mediated septic shock and inflammation via inhibiting NLRP3 inflammasome activation","volume":"81","author":"Hou","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"key20260514105821_b12-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jphs.2015.04.005","article-title":"Anti-inflammatory effects of glaucocalyxin B in microglia cells","volume":"128","author":"Gan","year":"2015","journal-title":"J Pharmacol Sci"},{"key":"key20260514105821_b13-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.3892\/mmr.2016.5450","article-title":"Glaucocalyxin B induces apoptosis and autophagy in human cervical cancer cells","volume":"14","author":"Pan","year":"2016","journal-title":"Mol Med Rep"},{"key":"key20260514105821_b14-ol-31-6-15622","first-page":"262","article-title":"Chemical constituents from Isodon suzhouensis and their anti-tumor activity","volume":"37","author":"Wei","year":"2024","journal-title":"Nat Prod Res Deve"},{"key":"key20260514105821_b15-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"116306","DOI":"10.1016\/j.jep.2023.116306","article-title":"Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula","volume":"309","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"key20260514105821_b16-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"218","DOI":"10.18433\/jpps32911","article-title":"Progress and prospects of research ideas and methods in the network pharmacology of traditional Chinese medicine","volume":"25","author":"Yuan","year":"2022","journal-title":"J Pharm Pharm Sci"},{"key":"key20260514105821_b17-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1083\/jcb.60.2.523","article-title":"Mathematical analysis of DNA distributions derived from flow microfluorometry","volume":"60","author":"Dean","year":"1974","journal-title":"J Cell Biol"},{"key":"key20260514105821_b18-ol-31-6-15622","first-page":"317","article-title":"Enhanced Chemosensitivty of Leukemic Cells to Cytarabine by Targeted Suppression of miRNA-21","volume":"15","author":"Zhu","year":"2011","journal-title":"Life Sci Res"},{"key":"key20260514105821_b19-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"3381","DOI":"10.1200\/JCO-25-01694","article-title":"Ziftomenib in relapsed or refractory NPM1-mutated AML","volume":"43","author":"Wang","year":"2025","journal-title":"J Clin Oncol"},{"key":"key20260514105821_b20-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: A review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol Adv"},{"key":"key20260514105821_b21-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"656","DOI":"10.3390\/ijms18030656","article-title":"Understanding the effectiveness of natural compound mixtures in cancer through their molecular mode of action","volume":"18","author":"Aung","year":"2017","journal-title":"Int J Mol Sci"},{"key":"key20260514105821_b22-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2131\/jts.37.891","article-title":"A method for detecting covalent modification of sensor proteins associated with 1,4-naphthoquinone-induced activation of electrophilic signal transduction pathways","volume":"37","author":"Hirose","year":"2012","journal-title":"J Toxicol Sci"},{"key":"key20260514105821_b23-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1021\/acschembio.5b00945","article-title":"Strategies and approaches of targeting STAT3 for cancer treatment","volume":"11","author":"Furtek","year":"2016","journal-title":"ACS Chem Biol"},{"key":"key20260514105821_b24-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"669363","DOI":"10.3389\/fcell.2021.669363","article-title":"JAK-STAT in early hematopoiesis and leukemia","volume":"9","author":"Fasouli","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"key20260514105821_b25-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1182\/blood.2022017416","article-title":"Biology and therapeutic targeting of molecular mechanisms in MPNs","volume":"141","author":"How","year":"2023","journal-title":"Blood"},{"key":"key20260514105821_b26-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"8261","DOI":"10.3390\/ijms21218261","article-title":"Targeting the JAK2\/STAT3 pathway-can we compare it to the two faces of the god janus?","volume":"21","author":"Ja\u015bkiewicz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20260514105821_b27-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1158\/1535-7163.MCT-22-0323","article-title":"JAK: Not just another kinase","volume":"21","author":"Agashe","year":"2022","journal-title":"Mol Cancer Ther"},{"key":"key20260514105821_b28-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s13046-019-1206-z","article-title":"STAT3 as a potential therapeutic target in triple negative breast cancer: A systematic review","volume":"38","author":"Qin","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"key20260514105821_b29-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"3846","DOI":"10.1172\/JCI31871","article-title":"Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas","volume":"117","author":"Gao","year":"2007","journal-title":"J Clin Invest"},{"key":"key20260514105821_b30-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s40265-017-0772-7","article-title":"JAK-STAT signaling as a target for inflammatory and autoimmune diseases: Current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"key":"key20260514105821_b31-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/s41575-020-0273-0","article-title":"JAK-STAT pathway targeting for the treatment of inflammatory bowel disease","volume":"17","author":"Salas","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"key20260514105821_b32-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1038\/onc.2009.202","article-title":"Stat3 promotes the development of erythroleukemia by inducing Pu.1 expression and inhibiting erythroid differentiation","volume":"28","author":"Hegde","year":"2009","journal-title":"Oncogene"},{"key":"key20260514105821_b33-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41419-020-2331-5","article-title":"The nuclear gene rpl18 regulates erythroid maturation via JAK2-STAT3 signaling in zebrafish model of Diamond-Blackfan anemia","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"key":"key20260514105821_b34-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1126\/science.aaw3607","article-title":"The therapeutic promise of apoptosis","volume":"363","author":"Fuchs","year":"2019","journal-title":"Science"},{"key":"key20260514105821_b35-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"518","DOI":"10.3390\/molecules23030518","article-title":"Melatonin and cancer hallmarks","volume":"23","author":"Talib","year":"2018","journal-title":"Molecules"},{"key":"key20260514105821_b36-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1039\/D5NA00323G","article-title":"Antibody-functionalized lipid nanocarriers for RNA-based cancer gene therapy: Advances and challenges in targeted delivery","volume":"7","author":"Nabih","year":"2025","journal-title":"Nanoscale Adv"},{"key":"key20260514105821_b37-ol-31-6-15622","doi-asserted-by":"publisher","first-page":"20815","DOI":"10.1039\/D5RA02640G","article-title":"Recent advances in nano vehicles encapsulating cinnamic acid and its derivatives as promising anticancer agents","volume":"15","author":"Wafik Nabih","year":"2025","journal-title":"RSC Adv"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T07:58:30Z","timestamp":1778745510000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2026.15622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,4,27]]}},"URL":"https:\/\/doi.org\/10.3892\/ol.2026.15622","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]}}}